Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated (Changed) | Updated to: 2026-04-01 | Was: 2026-03-27 |
| Drug Identification Number | 02243676 | 02243676 |
| Brand name | RECOMBIVAX HB | RECOMBIVAX HB |
| Common or Proper name | (hepatitis B vaccine [recombinant]) | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | HEPATITIS B SURFACE ANTIGEN | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG | 10MCG |
| Dosage form(s) | SUSPENSION SOLUTION | SUSPENSION SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10MCG/1ML 1DOSE | 10MCG/1ML 1DOSE |
| Additional packaging sizes | ||
| ATC code | J07BC | J07BC |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2026-04-10 | 2026-04-10 |
| Actual discontinuation date | ||
| Remaining supply date | 2026-04-10 | 2026-04-10 |
| Discontinuation status | To be discontinued | To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments (Changed) | Updated to: RECOMBIVAX HB® (10 mcg/mL) vials will be discontinued and replaced by RECOMBIVAX HB® (10 mcg/mL) pre-filled syringes | Was: |
| Health Canada comments |